Market Watch Highlights: Sage Therapeutics Inc (SAGE) Ends on an Upturn Note at 10.90

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

As of close of business last night, Sage Therapeutics Inc’s stock clocked out at $10.90, up 3.02% from its previous closing price of $10.58. In other words, the price has increased by $3.02 from its previous closing price. On the day, 1.2 million shares were traded. SAGE stock price reached its highest trading level at $11.01 during the session, while it also had its lowest trading level at $10.19.


To gain a deeper understanding of SAGE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.22 and its Current Ratio is at 12.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 29, 2024, initiated with a Neutral rating and assigned the stock a target price of $15.

On May 29, 2024, Citigroup started tracking the stock assigning a Sell rating and target price of $8.

BofA Securities Downgraded its Neutral to Underperform on April 17, 2024, whereas the target price for the stock was revised from $24 to $14.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 09 ’23 when Barrett Elizabeth bought 2,000 shares for $18.64 per share. The transaction valued at 37,279 led to the insider holds 3,000 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAGE now has a Market Capitalization of 655983808 and an Enterprise Value of -57722864. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.20 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at -0.634 whereas that against EBITDA is 0.114.

Stock Price History:

Over the past 52 weeks, SAGE has reached a high of $59.99, while it has fallen to a 52-week low of $10.44. The 50-Day Moving Average of the stock is -18.83%, while the 200-Day Moving Average is calculated to be -43.58%.

Shares Statistics:

It appears that SAGE traded 1.10M shares on average per day over the past three months and 1101930 shares per day over the past ten days. A total of 60.04M shares are outstanding, with a floating share count of 49.49M. Insiders hold about 17.76% of the company’s shares, while institutions hold 90.58% stake in the company. Shares short for SAGE as of 1715731200 were 8456241 with a Short Ratio of 7.67, compared to 1713139200 on 9310631. Therefore, it implies a Short% of Shares Outstanding of 8456241 and a Short% of Float of 15.959999999999999.

Most Popular